Back to Top Skip to main content Skip to sub-navigation

Zapping mosquitoes from the inside out

While chemical mosquito population control measures have been used with some degree of success, they are toxic to other insect populations and to the health of humans. A different angle of defense has emerged, which is genetic modification of the mosquito itself, making it transgenic. Transgenic mosquitoes are unable to transmit a pathogen, such as malaria, due to their altered genetic makeup. (DoD photo) While chemical mosquito population control measures have been used with some degree of success, they are toxic to other insect populations and to the health of humans. A different angle of defense has emerged, which is genetic modification of the mosquito itself, making it transgenic. Transgenic mosquitoes are unable to transmit a pathogen, such as malaria, due to their altered genetic makeup. (CDC photo)

Recommended Content:

Mosquito-Borne Illnesses | Zika Virus | Preventing Mosquito-Borne Illnesses | Medical and Dental Preventive Care Fitness | Innovation | Medical Research and Development | Deployment Health

Mosquitoes aren’t just annoying at summer barbecues. In many parts of the world, they carry pathogens for Zika, dengue, yellow fever, and the most devastating of mosquito-borne diseases, malaria. According to the Centers for Disease Control and Prevention, 440,000 people died in sub-Saharan Africa in 2016 from malaria, contracted from the bite of infected female Anopheles mosquitoes. Malaria causes severe chills, high fever, profuse sweating, and other flu-like symptoms, and if left untreated, can lead to death. Protecting U.S. military personnel who continue to serve in this part of world is critical.

The Department of Defense Armed Forces Pest Management Board has curated various personal protective repellant systems for deployed service members: permethrin-treated uniforms, application of insect repellants such as DEET and Picaridin, permethrin-impregnated bed nets, and prescribed antimalarial medication. They also oversee the Deployed Warfighter Protection Research Program that studies how to mitigate a variety of insect threats to military personnel.

While chemical mosquito population control measures have been used with some degree of success, they are toxic to other insect populations and to the health of humans. A different angle of defense has emerged, which is genetic modification of the mosquito itself, making it transgenic. Transgenic mosquitoes are unable to transmit a pathogen, such as malaria, due to their altered genetic makeup.

The concept of transgenic mosquitoes has been around since the 1980s, although the first laboratory colony wasn’t developed until 1997, according to Dr. Marcelo Ramalho-Ortigao, associate professor of preventive medicine in the Department of Preventive Medicine and Biostatistics at the Uniformed Services University in Bethesda, Maryland. There are currently two methods used to control mosquito-borne diseases using transgenic mosquitoes. One is population replacement using a concept known as “gene drive” to spread anti-pathogen genes. The other is a population suppression strategy that reduces the number of mosquitoes that can pass on the pathogen.

So far, the idea of using transgenic mosquitoes to combat malaria has been tested in laboratory settings only. However, successful genetic modification of a particular species of mosquito, Aedes aegypti — known to spread the Zika, dengue, yellow fever, and chikungunya viruses — has been both laboratory and field tested by Oxitec, a United Kingdom-based company.

“This field of study and research has changed dramatically since the discovery and advent of the gene-editing technology known as CRISPR-Cas9, as the speed and the number of genes that can be targeted has increased,” explained Ramalho-Ortigao. Field tests of mosquitoes modified using the CRISPR technology are still in the research and development phase.

Because of the ethical ramifications of gene editing to alter mosquitoes or other species, this concept has always been controversial, Ramalho-Ortigao said. “Controversy and discussions with regard to applications, and especially how to control against unwanted effects, is critical for the advancement of science, especially with regard to transgenic technologies.” Government regulation by the Food and Drug Administration and the Environmental Protection Agency is a way to ensure studies do not deviate from their scientific goals, he added.

In addition to potentially proving a new tool in the fight against mosquito-borne diseases, “studies of insect transgenics also provide crucial training for the next generation of scientists who may be involved in cutting-edge research and possibly apply techniques they learned using mosquitoes or other insects as a model for higher organisms,” explained Ramalho-Ortigao. He pointed out that insects “share many common features with vertebrates with regard to gene expression, ability to mount an immune response to invading microorganisms and viruses, and certain behavioral traits.” Scientists may therefore be able to apply knowledge gained about insects toward organisms “higher in the evolutionary scale, including vertebrates,” he said.

Although humans may not miss mosquitoes if they were to be eradicated, our ecosystem would. “Mosquitoes play an important role as pollinators," said Ramalho-Ortigao. “Also, they are a food source for other insects, spiders, frogs, lizards, and birds.” He added that not all mosquitoes transmit disease and only females blood feed, which allows them to lay eggs. In fact, of the nearly 3,000 known mosquito species, only a fraction transmit diseases. Complete elimination could lead to the expansion of other species or an increase of the population of a species that is currently present in smaller numbers – creating a whole new bug problem.

You also may be interested in...

Deployment Health Research Center External Review

Presentation
9/5/2008

Deployment Health Research Center External Review presented to the Defense Health Board Sept. 5, 2008

Recommended Content:

Deployment Health | Research and Innovation

Biowarfare Countermeasures Subcommittee Update

Presentation
9/4/2008

Biowarfare Countermeasures Subcommittee Update presented to the Defense Health Board Sept. 4, 2008

Recommended Content:

Deployment Health

Evidence Based Accession Deployment and Retention Military Medical Standards

Report
7/9/2008

Defense Health Board: Evidence Based Accession Deployment and Retention Military Medical Standards

Recommended Content:

Deployment Health

Health Risk Assessment Burn Pit Exposures Balad Air Base Iraq

Report
6/26/2008

Defense Health Board: Health Risk Assessment Burn Pit Exposures Balad Air Base Iraq

Recommended Content:

Deployment Health | Environmental Exposures

Emergency Blood Transfusions in Combat Theaters and Impact on HIV Testing Policy

Report
6/2/2008

Defense Health Board: Emergency Blood Transfusions in Combat Theaters and Impact on HIV Testing Policy

Recommended Content:

Deployment Health

Health Risk Assessment Burn Pit Exposures at Balad Air Base

Presentation
4/24/2008

Health Risk Assessment Burn Pit Exposures at Balad Air Base presented to the Defense Health Board April 24, 2008

Recommended Content:

Deployment Health

POST-DEPLOYMENT HEALTH ASSESSMENT (PDHA)

Policy

POST-DEPLOYMENT HEALTH RE-ASSESSMENT (PDHRA)

Policy

Report of the Department of Defense Task Force on Mental Heath

Report
6/1/2007

Defense Health Board: Report of the Department of Defense Task Force on Mental Heath

Recommended Content:

Health Readiness | Public Health | Deployment Health

ASD (HA) Memo "TBI Questions for the Post Deployment Health Assessment"

Policy

Policy Guidance for Deployment-Limiting Psychiatric Conditions and Medications

Policy

This policy provides guidance on deployment and continued service in a deployed environment for military personnel who experience psychiatric disorders and/or who are prescribed psychotropic medication.

Joint Publication 4-02, Health Service Support

Policy

Policy for Pre- and Post-deployment Serum Collection

Policy

The reference, responding to the 2005 National Defense Authorization Act (Section 733), established interim standards for the collection of pre-and postdeployment blood specimens. It also authorized the Joint Medical Readiness Oversight Committee (JMROC) to recommend changes to the interim standards.

  • Identification #: 06-008
  • Date: 3/14/2006
  • Type: Memorandums
  • Topics: Deployment Health

Periodic Health Assessment Policy for Active Duty and Selected Reserve Members

Policy

This policy explains the requirement to perform annual Periodic Health Assessments (PHAs) for all members of the Active Duty and the Selected Reserve (SELRES) members.

Policy Guidance for Medical Deferral Pending Deployment to Theaters of Operation

Policy
<< < ... 11 12 13 14 15  ... > >> 
Showing results 211 - 225 Page 15 of 16

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.